Science AAASMale mice bequeath an unexpected legacy to their progeny. Two studies published in Science reveal that sperm from the rodents carry pieces of RNAs that alter the metabolism of their offspring. The RNAs spotlighted by the studies normally help synthesize proteins, so the findings point to an unconventional form of inheritance. The results are “exciting and surprising, but not impossible,” says geneticist Joseph Nadeau of the Pacific Northwest Diabetes Research Institute in Seattle, Washington.READ MORE

NPREvery once in a while a technology comes along that completely alters the way scientists do their work.
It's hard to imagine astronomy without a telescope or high energy physics without an accelerator.
From here on in, it's going to be impossible to imagine biology without CRISPR-Cas9.READ MORE

AIDS Healthcare FoundationFounded in 1987, AIDS Healthcare Foundation is the largest specialized provider of HIV/AIDS medical care in the nation. Our mission is to provide cutting edge medicine and advocacy, regardless of ability to pay. Through our healthcare centers, pharmacies, health plan, research and other activities, AHF provides access to the latest HIV treatments for all who need them.READ MORE

Genetic Engineering & Biotechnology NewsThe genome is not as static as a well-tended garden. It has its wild side. New genes emerge continuously. Some even sprout like weeds from genomic regions once devoid of functional DNA. These seemingly unlikely outgrowths needn’t be copies or modified versions of existing genes. Instead, they can be entirely new, pushing evolutionary processes in new directions, especially if they become intensively cultivated—transcriptionally speaking.READ MORE

Health Data ManagementNantHealth, which has designed genomic and protein-based molecular diagnostic testing services and a technology platform to support personalized cancer care, has acquired NaviNet Inc., a major vendor of financial and clinical transactions processing services.READ MORE

Phys.orgStem cell activity in the outer lining of the ovary, now identified in mice by A*STAR researchers, will elucidate normal ovarian activity and offer insights into the origins of disease.
Ovarian cancer kills more than 150,000 women globally each year, but the molecular and cellular events behind it remain unclear.READ MORE

Medical XpressA new technique for programming human stem cells to produce different types of tissue on demand may ultimately allow personalized organs to be grown for transplant patients.
The technique, which also has near-term implications for growing organ-like tissues on a chip, was developed by researchers at MIT and is unveiled in a study published today in the journal Nature Communications.READ MORE

ForbesThere’s connected health tech in the air at CES 2016, Jan 6-9, 2016 in Las Vegas this year. From the emergence of the quantified self to the Internet of Things, with a predicted 30 billion objects to be connected by 2020 according to McKinsey, it’s safe to say there’s a shift taking place when it comes to our relationships with ourselves, our doctors and clinics and hospitals.READ MORE

ModernMedicineIt wasn’t only the aging demographic that prompted high-tech firms to throw their hats in the healthcare ring. Nor was it the market opportunities created by the Affordable Care Act, or investor enthusiasm for software solutions that may solve some of the healthcare industry’s most pressing problems. It was all three.
Over the last five years, tech titans including Google, Intel, IBM and Apple have set their sights on the roughly $40 billion healthcare IT market, joining a proliferation of Silicon Valley startups that are developing new products to help achieve the “Triple Aim” of better care, improved outcomes, and lower costs. READ MORE

Reuters via Fox NewsThe U.S. Food and Drug Administration said it had taken steps to strengthen the data requirements for surgical mesh devices when used to repair pelvic organ prolapse via the vagina.
POP occurs when the muscles and tissue of the pelvic floor become stretched, torn or weakened and can no longer support pelvic organs, leading to their prolapse into the vagina.READ MORE

Becker's Hospital ReviewAccountable care organizations have grown rapidly as a healthcare delivery model over the last several years. While analysts expect the momentum to continue, the future of ACOs is uncertain.
In a new report from Leavitt Partners called "Projected Growth of Accountable Care Organizations," analysts present how the ACO model is likely to grow under four possible future scenarios. As of December, Leavitt Partners estimates there are 23.3 million lives covered by ACOs.READ MORE

FierceHealthFinanceAccountable care organizations, like R-rated movies and taverns, seem to be mostly havens for adults. But how do ACOs for pediatric patients fare financially?
That question was asked by Children's Hospitals and Clinics of Minnesota, which examined an ACO that the provider had set up specifically to address the treatment of children enrolled in Medicaid who were suffering from chronic conditions. READ MORE

The Wall Street JournalA growing number of people are turning to healthcare ministries to cover their medical expenses instead of buying traditional insurance, a trend that could challenge the stability of the Affordable Care Act.
The ministries, which operate outside the insurance system and aren’t regulated by states, provide a healthcare cost-sharing arrangement among people with similarly held beliefs.READ MORE

CBS NewsTax filing is getting even more complicated. The Affordable Care Act requires employers and health insurance companies to give the IRS information about your income and health insurance coverage. So, the IRS has created three new tax forms, and you'll need them to prove you have health insurance and, therefore, aren't required to pay any tax penalties. You'll also need them to make a claim for tax credits you're entitled to.READ MORE

Seattle Genetics Announces FDA Regular Approval of ADCETRIS® for Classical Hodgkin Lymphoma Patients at High Risk of Relapse or Progression. Click here to view more information.

We wanted you to be aware that the FDA has granted accelerated approval of IBRANCE® (palbociclib) for the treatment of postmenopausal women with ER+/HER2- advanced breast cancer. Click here to see the press release!

Sandoz, a Novartis company, announced today that Zarxio(TM) (filgrastim-sndz) is now available in the United States. Zarxio is the first biosimilar approved by the US Food and Drug Administration (FDA) and the first to launch in the US. Please click here for more information.
.